RE:RE:RE:RE:Is this good news ?The fact that they didn't announce the price of the PP's shares and it's warrants means they are still uncertain what the smart money will pay. This will be a good test to see what the market presently values this company when stripped of the daily trading that can flucuate a sp. Their hoping the full $15M can be reached as that would negate another PP in the middle of the phase 2 trial. For shareholders whether the PP is fully subscribed will be an important indication of the current market sentiment for the science. Ideally you would want the PP oversubscribed. That would add a level of confidence the market is behind you.